Please use this identifier to cite or link to this item:
|Title:||Pharmaceutical development of novel microalgal compounds for Mdr Mycobacterium tuberculosis|
Bhimba, B Valentin
|Series/Report no.:||Int. cl.7 — A61K 35/80, A61P 31/06|
|Abstract:||The role of marine algae in the discovery of drugs that could reach the pharmaceutical market has increased notably in recent years, due to a substantial improvement in biological screening methods. Multi Drug Resistant (MDR) TB is the major hurdle in the TB control programmes. The selected resistant strains of Mycobacterium tuberculosis were screened for the bioactive compounds extracted from marine microalgae. It is noted that Isochrysis galbana has rich bioactive compounds than the other algal species.|
|ISSN:||0975-1092 (Online); 0972-592X (Print)|
|Appears in Collections:||NPR Vol.4(4) [July-August 2005]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.